Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Electronic Book
|
![]() |
|
2 |
Material Type: Article
|
![]() |
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic ArthritisMease, Philip J ; McInnes, Iain B ; Kirkham, Bruce ; Kavanaugh, Arthur ; Rahman, Proton ; van der Heijde, Désirée ; Landewé, Robert ; Nash, Peter ; Pricop, Luminita ; Yuan, Jiacheng ; Richards, Hanno B ; Mpofu, ShephardThe New England journal of medicine, 2015-10-01, Vol.373 (14), p.1329-1339 [Peer Reviewed Journal]Full text available |
3 |
Material Type: Article
|
![]() |
Enthesitis: from pathophysiology to treatmentSchett, Georg ; Lories, Rik J ; D'Agostino, Maria-Antonietta ; Elewaut, Dirk ; Kirkham, Bruce ; Soriano, Enrique R ; McGonagle, DennisNature reviews. Rheumatology, 2017-11-21, Vol.13 (12), p.731-741 [Peer Reviewed Journal]Full text available |
4 |
Material Type: Article
|
![]() |
Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisKirkham, Bruce W ; Kavanaugh, Arthur ; Reich, KristianImmunology, 2014-02, Vol.141 (2), p.133-142 [Peer Reviewed Journal]Full text available |
5 |
Material Type: Article
|
![]() |
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trialSterry, Wolfram ; Ortonne, Jean-Paul ; Kirkham, Bruce ; Brocq, Olivier ; Robertson, Deborah ; Pedersen, Ronald D ; Estojak, Joanne ; Molta, Charles T ; Freundlich, BruceBMJ, 2010, Vol.340 (7741), p.300-300 [Peer Reviewed Journal]Full text available |
6 |
Material Type: Article
|
![]() |
i144 Update from BRITPACKirkham, BruceRheumatology (Oxford, England), 2018-04-01, Vol.57 (suppl_3)Full text available |
7 |
Material Type: Article
|
![]() |
Presence, function, and regulation of IL‐17F‐expressing human CD4+ T cellsBurns, Lachrissa A ; Maroof, Ash ; Marshall, Diane ; Steel, Kathryn J. A ; Lalnunhlimi, Sylvine ; Cole, Suzanne ; Catrina, Anca ; Kirkham, Bruce ; Taams, Leonie SEuropean journal of immunology, 2020-04, Vol.50 (4), p.568-580 [Peer Reviewed Journal]Full text available |
8 |
Material Type: Article
|
![]() |
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritisFautrel, Bruno ; Alten, Rieke ; Kirkham, Bruce ; de la Torre, Inmaculada ; Durand, Frederick ; Barry, Jane ; Holzkaemper, Thorsten ; Fakhouri, Walid ; Taylor, Peter CRheumatology international, 2018-06, Vol.38 (6), p.935-947 [Peer Reviewed Journal]Full text available |
9 |
Material Type: Article
|
![]() |
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III StudyCoates, Laura C ; Mease, Philip J ; Gossec, Laure ; Kirkham, Bruce ; Sherif, Bintu ; Gaillez, Corine ; Mpofu, Shephard ; Jugl, Steffen M ; Karyekar, Chetan ; Gandhi, Kunal KArthritis care & research (2010), 2018-10, Vol.70 (10), p.1529-1535 [Peer Reviewed Journal]Full text available |
10 |
Material Type: Article
|
![]() |
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UKBuchanan, Vanessa ; Sullivan, Will ; Graham, Chris ; Miles, LaStella ; Jugl, Steffen Marc ; Gunda, Praveen ; Halliday, Anna ; Kirkham, BrucePharmacoEconomics, 2018-07, Vol.36 (7), p.867-878 [Peer Reviewed Journal]Full text available |